Strategic partnerships AccessDx has active collaborations and integrations with healthcare technology platforms such as PointClickCare and partnerships with care providers like Spartanburg Ob-Gyn to offer pharmacogenomics testing, signaling opportunities to cross-sell integrated genomic services to clinical networks and payers.

Expansion readiness Licensed to operate in all 50 states including key markets like New York and California, indicating a scalable distribution footprint and readiness to pursue multi-state contracts, hospital systems, and academic medical centers.

Precision medicine focus Emphasis on pharmacogenomics and therapeutic drug monitoring within proprietary solutions positions AccessDx as a partner for hospitals and clinics expanding personalized medicine programs and value-based care initiatives.

Recent showings Frequent participation and exhibit presence at major industry events (ASCP and NCDONA) in 2025 suggest active branding, lead generation, and opportunities to engage hospital labs, nursing homes, and long-term care providers.

Financial scale Revenue range of 25–50 million with a leaner team size (50–200 employees) indicates opportunities for mid-market collaboration, bundled service offerings, and scalable diagnostic programs that can be deployed across regional networks.